Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fulgent Genetics, Inc. Director's Dealing 2020

Dec 22, 2020

32553_dirs_2020-12-22_44c42e7b-4449-43ef-80e8-5256dd96c82b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-12-15

Reporting Person: Ming Hsieh Trust (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7895115 Direct

Footnotes

F1: The reported securities were transferred to the reporting person for no consideration by Ming Hsieh, the President, Chief Executive Officer and Board of Directors of the issuer, for estate planning purposes. Mr. Hsieh is the trustee of the reporting person and possesses the sole voting and dispositive power with respect to the reported securities.